Dr. David Sciberras

Spent 25 years at Merck, GE Healthcare, Amgen and UCB managing early phase drug development in a wide variety of therapeutic areas. Responsibilities included first in human, proof of concept and supporting clinical pharmacology programme for late phase development. Led the implementation of microsampling (VAMS) in 2 global UCB development programmes.

Previous committee member of clinical section of British Pharmacological Society and Chair for Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI). Previous Chair of ABPI Experimental Medicines Group.

"Sound data drive successful innovation."